Published in Z Arztl Fortbild Qualitatssich on January 01, 2006
Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer (2012) 0.94
Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT. Br J Cancer (2008) 0.90
Quality of life diagnosis and therapy as complex intervention for improvement of health in breast cancer patients: delineating the conceptual, methodological, and logistic requirements (modeling). Langenbecks Arch Surg (2007) 0.89
Quality of reporting of complex healthcare interventions and applicability of the CReDECI list - a survey of publications indexed in PubMed. BMC Med Res Methodol (2013) 0.84
Breast cancer survivors' recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial. BMC Cancer (2015) 0.77
Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol (2007) 1.88
Mild preseptic hypothermia is detrimental in rats. Crit Care Med (2004) 1.74
FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. Eur Urol (2007) 1.72
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clin Cancer Res (2006) 1.66
Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm Bowel Dis (2008) 1.61
Association of antibodies to exocrine pancreas with subtypes of Crohn's disease. Eur J Gastroenterol Hepatol (2005) 1.53
Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis. Crit Care Med (2006) 1.48
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol (2012) 1.46
Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor. Anesthesiology (2003) 1.45
Sequential therapy of primary cardiac lymphoma with cardiectomy, total artificial heart support, and cardiac transplantation. J Heart Lung Transplant (2010) 1.44
Quality of life in animals as a new outcome for surgical research: G-CSF as a quality of life improving factor. Eur Surg Res (2002) 1.40
Solitary and small (≤3 mm) apical positive surgical margins are related to biochemical recurrence after radical prostatectomy. Int J Urol (2011) 1.40
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2011) 1.38
Dead Sea treatment - principle for outpatient use in atopic dermatitis: safety and efficacy of synchronous balneophototherapy using narrowband UVB and bathing in Dead Sea salt solution. Eur J Dermatol (2002) 1.37
Global levels of histone modifications predict prostate cancer recurrence. Prostate (2010) 1.11
Salvage therapy in patients with glioblastoma: is there any benefit? Cancer (2003) 1.11
Quality of life: a deconstruction for clinicians. J R Soc Med (2002) 1.10
Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol (2009) 1.07
A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One (2012) 1.07
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol (2016) 1.04
Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients' survival. Thyroid (2008) 1.04
Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. Eur Urol (2012) 1.03
Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol (2005) 1.03
[Short version of the guideline "Early Detection of Breast Cancer in Germany"]. Z Arztl Fortbild Qualitatssich (2004) 1.03
Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma. Hum Pathol (2005) 1.02
Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era. Am J Clin Pathol (2005) 1.02
Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark (2007) 0.98
The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. J Thorac Oncol (2016) 0.98
Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer. Int J Cancer (2006) 0.95
[The German program for disease management guidelines. Background, methods, and development process]. Med Klin (Munich) (2006) 0.92
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol (2010) 0.91
Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation. Int J Cancer (2012) 0.91
Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer. Virchows Arch (2014) 0.90
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int (2010) 0.89
Quality of life diagnosis and therapy as complex intervention for improvement of health in breast cancer patients: delineating the conceptual, methodological, and logistic requirements (modeling). Langenbecks Arch Surg (2007) 0.89
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. Liver Int (2005) 0.89
Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease. Inflamm Bowel Dis (2003) 0.89
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients. Clin Genitourin Cancer (2013) 0.89
A case of recurrent gastrointestinal bleeding and protein-losing gastroenteropathy. Nat Clin Pract Gastroenterol Hepatol (2007) 0.87
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer. BMC Cancer (2012) 0.87
Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Invest (2011) 0.87
Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease. Int J Colorectal Dis (2004) 0.87
Alterations of global histone H4K20 methylation during prostate carcinogenesis. BMC Urol (2012) 0.86
Gender-dependent cancer-specific survival following radical cystectomy. World J Urol (2011) 0.86
Quality of life of patients with maxillofacial defects after treatment for malignancy. Int J Prosthodont (2005) 0.86
[A concept for the implementation and evaluation of the guideline "Early Detection of Breast Cancer in Germany"]. Z Arztl Fortbild Qualitatssich (2004) 0.86
Outcome and quality of life in medicine: a conceptual framework to put quality of life research into practice. Urol Oncol (2005) 0.85
Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125. BMC Cancer (2014) 0.85
Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis. World J Surg (2004) 0.85
Relation between severe illness and non-completion of quality-of-life questionnaires by patients with rectal cancer. J R Soc Med (2003) 0.85
Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hum Pathol (2003) 0.85
Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk. Int J Clin Exp Pathol (2013) 0.85
Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder. Scand J Urol Nephrol (2009) 0.85
Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer (2014) 0.84
Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry. Ann Hematol (2011) 0.84
Histopathological parameters as predictors for the course of Crohn's disease. Virchows Arch (2003) 0.83
A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany. Int J Colorectal Dis (2011) 0.83
Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation. Clin Cancer Res (2004) 0.83
Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis. BMC Cancer (2014) 0.83
Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. Arch Dermatol (2006) 0.83
[In the balance: the central role of outcome in guidelines and disease management programs]. Z Arztl Fortbild Qualitatssich (2003) 0.83
Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study. Nephrol Dial Transplant (2006) 0.82
Integrated outcome assessment after anterior cervical discectomy and fusion: myelocompression but not adjacent instability affect patient-reported quality of life and cervical spine symptoms. Spine (Phila Pa 1976) (2004) 0.82
Perioperative prophylaxis with granulocyte colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery: A randomized, controlled trial. Surgery (2007) 0.82
Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. Arch Pathol Lab Med (2003) 0.82
TNF-independent development of transient anemia of chronic disease in a mouse model of protracted septic peritonitis. Lab Invest (2003) 0.82
Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis. Mod Pathol (2002) 0.81
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer (2010) 0.81
Interdigitating dendritic cell sarcoma of the leg. Onkologie (2009) 0.81
The genetic background of hypertensive, septic rats determines outcome improvement with antibiotic and G-CSF prophylaxis. Shock (2003) 0.81
The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol (2014) 0.80
Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population. J Cancer (2011) 0.80
Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients. Urol Int (2014) 0.80
Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer. Anticancer Res (2012) 0.80
Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma. Ann Hematol (2011) 0.80
Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Mol Med Rep (2012) 0.79
Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat (2006) 0.78
Differential effects of antibiotics in combination with G-CSF on survival and polymorphonuclear granulocyte cell functions in septic rats. BMC Infect Dis (2008) 0.77
Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage. World J Urol (2014) 0.77
Failure of interferon-gamma and tumor necrosis factor in mediating anemia of chronic disease in a mouse model of protracted septic peritonitis. Int J Mol Med (2005) 0.77
[Guidelines in the AWMF system: position and perspectives]. Z Arztl Fortbild Qualitatssich (2003) 0.76
Histone methylation defines an epigenetic entity in penile squamous cell carcinoma. J Urol (2012) 0.76
Hyaline globules in paucicellular leiomyomas of the gastrointestinal tract are distinct from skeinoid fibers and represent degenerating smooth muscle cells. Pathol Res Pract (2009) 0.76
Study types and study issues in clinical medicine. Forensic Sci Int (2006) 0.75
Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol (2011) 0.75
Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder. Pathol Res Pract (2011) 0.75
[Utilities: a solution of a decision problem?]. Z Evid Fortbild Qual Gesundhwes (2008) 0.75
From clinical evidence to everyday practice: implementing findings from a cost-effectiveness analysis for endoscopic injection therapy for upper-gastrointestinal bleeding. Eur J Gastroenterol Hepatol (2003) 0.75